|
|
Previous Article | Table of Contents | Next Article 
Antibodies in sulfonamide-induced immune thrombocytopenia recognize
calcium-dependent epitopes on the glycoprotein IIb/IIIa complex
BR Curtis, JG McFarland, GG Wu, GP Visentin and RH Aster
Blood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee
53233-2194.
Drug-dependent IgG antibodies (DDAb) induced by sulfamethoxazole (SMX) and
sulfisoxazole (SIX) were identified by flow cytometry in 15 patients who
developed thrombocytopenia while taking one of these medications. Fourteen
of the 15 DDAb were specific solely for the glycoprotein (GP)IIb/IIIa
complex, and 13 of these reacted wholly or in part with epitopes present
only on the intact GPIIb/IIIa heterodimer. None of 12 SMX-induced DDAb
cross-reacted with SIX, but one of three SIX-induced antibodies reacted
with SMX. Each of 10 SMX-induced DDAb tested reacted with the N1-acetyl
metabolite of SMX, but only one reacted fully with the N4-acetyl
derivative. Detection of the SMX- and SIX-dependent antibodies was
facilitated by using bovine serum albumin (BSA) to achieve suspension of
these weakly soluble drugs in an aqueous medium. Our findings indicate that
DDAb induced by SMX and SIX, in contrast to those induced by quinidine and
quinine, are mainly specific for GPIIb/IIIa and react preferentially with
calcium-dependent epitopes present only on the intact GPIIb/IIIa
heterodimer.
Volume 84,
Issue 1,
pp. 176-183,
07/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Von Drygalski, B. R. Curtis, D. W. Bougie, J. G. McFarland, S. Ahl, I. Limbu, K. R. Baker, and R. H. Aster
Vancomycin-Induced Immune Thrombocytopenia
N. Engl. J. Med.,
March 1, 2007;
356(9):
904 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Bougie, P. R. Wilker, and R. H. Aster
Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies
Blood,
August 1, 2006;
108(3):
922 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Asvadi, Z. Ahmadi, and B. H. Chong
Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies
Blood,
September 1, 2003;
102(5):
1670 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Bougie, P. R. Wilker, E. D. Wuitschick, B. R. Curtis, M. Malik, S. Levine, R. N. Lind, J. Pereira, and R. H. Aster
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
Blood,
August 28, 2002;
100(6):
2071 - 2076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Curtis, J. Swyers, A. Divgi, J. G. McFarland, and R. H. Aster
Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets
Blood,
March 15, 2002;
99(6):
2054 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bougie and R. Aster
Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen
Blood,
June 15, 2001;
97(12):
3846 - 3850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kroll, Q.-H. Sun, and S. Santoso
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia
Blood,
August 15, 2000;
96(4):
1409 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Curtis, J. T. Edwards, M. J. Hessner, J. P. Klein, and R. H. Aster
Blood group A and B antigens are strongly expressed on platelets of some individuals
Blood,
August 15, 2000;
96(4):
1574 - 1581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bednar, J. J. Cook, M. A. Holahan, M. E. Cunningham, P. A. Jumes, R. A. Bednar, G. D. Hartman, and R. J. Gould
Fibrinogen Receptor Antagonist-Induced Thrombocytopenia in Chimpanzee and Rhesus Monkey Associated With Preexisting Drug-Dependent Antibodies to Platelet Glycoprotein IIb/IIIa
Blood,
July 15, 1999;
94(2):
587 - 599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Peterson, G. P. Visentin, P. J. Newman, and R. H. Aster
A Recombinant Soluble Form of the Integrin alpha IIbbeta 3 (GPIIb-IIIa) Assumes an Active, Ligand-Binding Conformation and Is Recognized by GPIIb-IIIa-Specific Monoclonal, Allo-, Auto-, and Drug-Dependent Platelet Antibodies
Blood,
September 15, 1998;
92(6):
2053 - 2063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Berkowitz, D. C. Sane, K. N. Sigmon, J. H. Shavender, R. A. Harrington, J. E. Tcheng, E. J. Topol, R. M. Califf, and for the Evaluation of c7E3 for the Prevention of I
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
J. Am. Coll. Cardiol.,
August 1, 1998;
32(2):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The Trial to Reduce Alloimmunization to Platelets
Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions
N. Engl. J. Med.,
December 25, 1997;
337(26):
1861 - 1870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hou, E. Horney, D. Stockelberg, S. Jacobsson, J. Kutti, and H. Wadenvik
Multiple Quinine-Dependent Antibodies in a Patient With Episodic Thrombocytopenia, Neutropenia, Lymphocytopenia, and Granulomatous Hepatitis
Blood,
December 15, 1997;
90(12):
4806 - 4811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bougie, S.T. Johnson, L.A. Weitekamp, and R.H. Aster
Sensitivity to a Metabolite of Diclofenac as a Cause of Acute Immune Hemolytic Anemia
Blood,
July 1, 1997;
90(1):
407 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|